LOC285033 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.569640E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.399600E-01
Normal-vs-Stage2
2.009600E-02
Normal-vs-Stage3
4.400400E-02
Normal-vs-Stage4
2.828800E-01
Stage1-vs-Stage2
4.775800E-01
Stage1-vs-Stage3
3.534100E-02
Stage1-vs-Stage4
9.357600E-01
Stage2-vs-Stage3
5.236100E-02
Stage2-vs-Stage4
6.213400E-01
Stage3-vs-Stage4
3.436500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.665510E-02
Normal-vs-AfricanAmerican
2.424800E-01
Normal-vs-Asian
6.279700E-02
Caucasian-vs-AfricanAmerican
4.668600E-01
Caucasian-vs-Asian
2.670600E-01
AfricanAmerican-vs-Asian
2.772800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.596000E-03
Normal-vs-Female
3.638300E-02
Male-vs-Female
5.750400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.614600E-01
Normal-vs-Age(41-60Yrs)
4.139900E-02
Normal-vs-Age(61-80Yrs)
1.370210E-02
Normal-vs-Age(81-100Yrs)
5.263900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.135800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.908000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.997400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.827200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.066000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.035600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.295800E-02
Normal-vs-Daily Drinker
2.126400E-01
Normal-vs-Weekly Drinker
8.133800E-02
Normal-vs-Occasional Drinker
3.274100E-02
Normal-vs-Social Drinker
2.393200E-01
Non Drinker-vs-Daily Drinker
5.107600E-01
Non Drinker-vs-Weekly Drinker
4.727600E-01
Non Drinker-vs-Occasional Drinker
6.938600E-01
Non Drinker-vs-Social Drinker
3.341500E-02
Daily Drinker-vs-Weekly Drinker
1.341040E-01
Daily Drinker-vs-Occasional Drinker
2.468000E-01
Daily Drinker-vs-Social Drinker
1.441490E-03
Weekly Drinker-vs-Occasional Drinker
7.002600E-01
Weekly Drinker-vs-Social Drinker
1.880250E-01
Occasional Drinker-vs-Social Drinker
6.465700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.546200E-01
Normal-vs-Grade 2
9.280000E-01
Normal-vs-Grade 3
8.884200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.495000E-01
Grade 1-vs-Grade 3
6.229600E-01
Grade 1-vs-Grade 4
8.546200E-01
Grade 2-vs-Grade 3
4.324600E-01
Grade 2-vs-Grade 4
9.280000E-01
Grade 3-vs-Grade 4
8.884200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.267900E-02
Normal-vs-NonDiabetic
8.195300E-03
Diabetic-vs-NonDiabetic
7.019600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.870010E-01
Normal-vs-NoPancreatitis
9.402900E-03
Pancreatitis-vs-NoPancreatitis
3.336600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.776300E-02
Normal-vs-N1
1.833530E-02
N0-vs-N1
8.309800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.256300E-02
Normal-vs-TP53-NonMutant
7.197900E-02
TP53-Mutant-vs-TP53-NonMutant
3.142200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
